跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROPYLTHIOURACIL TABLETS BP 50 mg - HSA Drug Approval Details
Approvals
/
HSA
/
PROPYLTHIOURACIL TABLETS BP 50 mg
Approved
THERAPEUTIC
PROPYLTHIOURACIL TABLETS BP 50 mg
PT ACTAVIS INDONESIA
🇸🇬 Health Sciences Authority
Approval Date
May 4, 1988
Approval ID
28046e2168d89653
Company
PT ACTAVIS INDONESIA
Type
Therapeutic
Approval Details
Approval Id
28046e2168d89653
Drug Name
PROPYLTHIOURACIL TABLETS BP 50 mg
Product Name
PROPYLTHIOURACIL TABLETS BP 50 mg
Approval Number
SIN00772P
Approval Date
1988-05-04
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
H03BA02
Atc Item Name
propylthiouracil
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
PROPYLTHIOURACIL
50 mg
PROPYLTHIOURACIL
50 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 4, 1988
Approval ID
28046e2168d89653
Type
Therapeutic
Back to HSA Approvals